Autolus Therapeutics (AUTL) Change in Account Payables (2022 - 2025)
Autolus Therapeutics posted quarterly Change in Account Payables of -$7.5 million for Q4 2025, down 2370.69% year-on-year from $331000.0 in Q4 2024, and down 238.65% on a QoQ basis from $5.4 million in Q3 2025.
Autolus Therapeutics (AUTL) has 4 years of Change in Account Payables data on file, last reported at -$7.5 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables fell 2370.69% year-over-year to -$7.5 million; the trailing twelve-month figure through Dec 2025 stood at $1.3 million (down 18.24% YoY), and the FY2025 full-year result was $1.3 million, down 18.24% from the prior year.
- Change in Account Payables for Q4 2025 stood at -$7.5 million, down from $5.4 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $5.4 million in Q3 2025 and bottomed at -$7.5 million in Q4 2025.
- The 4-year median for Change in Account Payables is $276000.0 (2024), against an average of $191538.5.
- Peak annual rise in Change in Account Payables reached 1864.13% in 2025, while the deepest fall reached 2370.69% in 2025.
- A 4-year view of Change in Account Payables shows it stood at $109000.0 in 2022, then tumbled by 630.28% to -$578000.0 in 2023, then surged by 157.27% to $331000.0 in 2024, then slumped by 2370.69% to -$7.5 million in 2025.
- The last three Change in Account Payables figures came in at -$7.5 million (Q4 2025), $5.4 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | -7.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.52 Mn |
| Dec 31, 2025 | -7.52 Mn |
| Sep 30, 2025 | 5.42 Mn |
| Sep 30, 2025 | 5.42 Mn |
| Jun 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.53 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 331,000.00 |
| Dec 31, 2024 | 331,000.00 |
| Sep 30, 2024 | 276,000.00 |
| Sep 30, 2024 | 276,000.00 |
| Jun 30, 2024 | -335,000.00 |
| Jun 30, 2024 | -335,000.00 |
| Mar 31, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | -578,000.00 |
| Dec 31, 2023 | -578,000.00 |
| Sep 30, 2023 | -3.19 Mn |
| Sep 30, 2023 | -3.19 Mn |
| Jun 30, 2023 | 3.49 Mn |
| Jun 30, 2023 | 3.49 Mn |
| Mar 31, 2023 | -227,000.00 |
| Mar 31, 2023 | -227,000.00 |
| Dec 31, 2022 | 109,000.00 |
| Dec 31, 2022 | 109,000.00 |